Financials Physitrack PLC

Equities

PTRK

GB00BK80TJ35

Healthcare Facilities & Services

Market Closed - Nasdaq Stockholm 08:57:37 2024-05-02 am EDT 5-day change 1st Jan Change
14 SEK -3.45% Intraday chart for Physitrack PLC -6.35% -13.58%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 92.49 34.96 23.66 19.51 - -
Enterprise Value (EV) 1 92.49 35.21 23.66 21.61 19.51 19.51
P/E ratio -94.8 x 215 x - - - -
Yield - - - - - -
Capitalization / Revenue 10.9 x 2.79 x 1.56 x 1.11 x 0.9 x 0.73 x
EV / Revenue 10.9 x 2.81 x 1.56 x 1.23 x 0.9 x 0.73 x
EV / EBITDA - 10.2 x 6.06 x 4.24 x 2.64 x 2.1 x
EV / FCF - -3,543,623 x - - - -
FCF Yield - -0% - - - -
Price to Book - 1.56 x - - - -
Nbr of stocks (in thousands) 16,261 16,261 16,261 16,261 - -
Reference price 2 5.688 2.150 1.455 1.200 1.200 1.200
Announcement Date 2/24/22 2/28/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 8.465 12.51 15.18 17.6 21.7 26.6
EBITDA 1 - - 3.446 3.907 5.1 7.4 9.3
EBIT 1 - - 1.013 0.2865 1.3 3.5 4.5
Operating Margin - - 8.09% 1.89% 7.39% 16.13% 16.92%
Earnings before Tax (EBT) - - 0.0511 - - - -
Net income 0.6884 - 0.0923 - - - -
Net margin - - 0.74% - - - -
EPS 0.0700 -0.0600 0.0100 - - - -
Free Cash Flow - - -9.936 - - - -
FCF margin - - -79.42% - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 6/8/21 2/24/22 2/28/23 2/28/24 - - -
1EUR in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 2.577 3.365 3.517 3.735 3.751 3.851 3.84 4.1 4.3 4.6 4.6
EBITDA 1 0.7498 0.917 0.8765 0.9221 0.9537 1.051 0.98 1.1 1.2 1.4 1.4
EBIT 1 0.426 0.2054 0.0601 0.1138 0.0529 0.1265 -0.0067 0.2 0.3 0.4 0.5
Operating Margin 16.53% 6.1% 1.71% 3.05% 1.41% 3.29% -0.17% 4.88% 6.98% 8.7% 10.87%
Earnings before Tax (EBT) -0.0764 -0.0143 0.4682 -0.153 - - - - - - -
Net income -0.1457 0.0167 0.6424 -0.0656 -0.2517 -0.2402 - - - - -
Net margin -5.66% 0.5% 18.26% -1.76% -6.71% -6.24% - - - - -
EPS -0.0100 - 0.0300 - - - - - - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 5/25/22 11/7/22 2/28/23 5/2/23 8/15/23 11/14/23 2/28/24 - - - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 0.25 - 2.1 - -
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - - 0.0737 x - 0.4118 x - -
Free Cash Flow - - -9.94 - - - -
ROE (net income / shareholders' equity) - - 4.36% - - - -
ROA (Net income/ Total Assets) - - 2.71% - - - -
Assets - - 3.412 - - - -
Book Value Per Share - - 1.380 - - - -
Cash Flow per Share - - - - - - -
Capex - - 4.5 - - - -
Capex / Sales - - 35.94% - - - -
Announcement Date 6/8/21 2/24/22 2/28/23 2/28/24 - - -
1EUR in Million
Estimates
  1. Stock Market
  2. Equities
  3. PTRK Stock
  4. Financials Physitrack PLC